CD47 and atherosclerosis: As macrophages are important players in development of atherosclerosis we cannot exclude their contribution to the observed phenotype, especially since the SIRPα counter-receptor CD47 appears involved in pathogenesis of atherosclerosis through inhibition, e.g., macrophage efferocytosis (50).